PHARMACOKINETICS, IMMUNOGENICITY, AND EXPOSURE–RESPONSE RELATIONSHIPS OF USTEKINUMAB TREATMENT IN PATIENTS WITH CROHN’S DISEASE: RESULTS FROM THE WEEK 48 TREAT TO TARGET VS STANDARD OF CARE ANALYSIS OF THE STARDUST STUDY
Silvio Danese 1
Severine Vermeire 2
Geert R. D'Haens 3
Omoniyi J. Adedokun 4
Julian Panés 5
Axel Dignass 6
Fernando Magro 7
Maciej Nazar
Marjolein Lahaye
Manuela Le Bars
Lioudmila Ni
Daniel R. Gaya
Ivana Bravata
Laurent Peyrin-Biroulet
1 Humanitas University,Milan,Italy
2 University Hospitals Leuven,Leuven,Belgium
3 University of Amsterdam,Amsterdam,Netherlands
4 Janssen Research & Development,Pennsylvania,United States
5 Hospital Clinic of Barcelona, IDIBAPS, CIBERehd,Barcelona,Spain
6 Agaplesion Markus Hospital,Frankfurt/Main,Germany
7 Institute for Molecular and Cel
Session
IBD (Posters)
Conference
UEG Week Virtual 2021
Citation
United European Gastroenterology Journal 2021; 9 (Supplement 1)
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]